| Course | DNP 677 Management of Complex and Chronic Mental Health Problems in Children, Adolescents and Adults Across the Lifespan |
|---|---|
| Module | Module 3 |
| Paper type | Evidence-based paper |
| Length | About 715 words, 5 pages |
| Format | APA 7 student paper |
| School | Arizona State University |
| Program | Doctor of Nursing Practice |
| Updated | October 2026 |
Free sample paper for DNP 677 Module 3
Fish Oil for the Blues? What the Evidence Says About Omega-3 Fatty Acids for Adults With Depression
Student Name
Edson College of Nursing and Health Innovation, Arizona State University
DNP 677: Management of Complex and Chronic Mental Health Problems in Children, Adolescents and Adults Across the Lifespan
Instructor Name
Month Day, Year
Fish Oil for the Blues? What the Evidence Says About Omega-3 Fatty Acids for Adults With Depression
Introduction
Many patients with depression ask whether fish oil can help, and some take it without telling their prescriber. Omega-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are found in oily fish and sold as supplements. Proposed reasons they might help include effects on inflammation and on brain cell membranes. This paper reviews the research on omega-3 supplements for treating and preventing depression in adults and considers how a psychiatric nurse practitioner can use that evidence.
Review of the Research
Treatment: the Cochrane review. The most rigorous summary is a Cochrane review of 35 studies. Compared with placebo, omega-3 supplements produced a small to modest reduction in depressive symptoms (standardized mean difference -0.40, 33 studies), but the authors judged this effect unlikely to be clinically meaningful: it equals about 2.5 points on the 17-item Hamilton scale, below the 3-point minimal clinically important change. The evidence was rated very low certainty, heterogeneity was considerable, and there was no difference in response or remission rates (Appleton et al., 2021).
Treatment: does the formula matter? A meta-analysis of 26 double-blind placebo-controlled trials with 2,160 participants found an overall benefit (SMD -0.28) and reported that the benefit was concentrated in formulas with at least 60% EPA, at doses of 1 g/day or less, while DHA-pure and DHA-major formulas showed no benefit (Liao et al., 2019).
Expert guidance. The International Society for Nutritional Psychiatry Research used a literature review and a Delphi process to produce practice guidelines. They advise a clinical interview and measurement-based assessment before recommending omega-3s, favor pure EPA or EPA-to-DHA ratios above 2:1, suggest 1 to 2 g of net EPA daily and call for monitoring of gastrointestinal and skin side effects (Guu et al., 2019).
Prevention: VITAL-DEP. In a randomized trial of 18,353 adults aged 50 or older without clinically relevant depression at baseline, five years of omega-3 supplementation did not prevent depression. The omega-3 group had slightly more cases of depression or clinically relevant symptoms than the placebo group (hazard ratio 1.13), and mood scores did not differ (Okereke et al., 2021).
Logic and Interpretation
The findings look contradictory, but they answer different questions. The Cochrane review asks whether omega-3s, as a group, treat depression, and finds a small effect of uncertain clinical value. The Liao meta-analysis suggests that pooling all formulas may hide a benefit from EPA-rich products, but its subgroup findings are exploratory and come from small trials. The guideline is consensus based, which makes it useful for practical questions such as formula and dose but weaker than trial evidence for efficacy. VITAL-DEP answers a different question altogether: whether omega-3s prevent depression in older adults who are not depressed, and they do not.
Taken together, the evidence does not support omega-3s as a replacement for established treatment of depression. It leaves room for EPA-rich omega-3s as an adjunct for some patients, with modest expectations, and it argues against recommending fish oil to prevent depression.
Relevance to Psychiatric Nursing Practice
Patients ask about supplements because they want some control over their treatment. A psychiatric nurse practitioner can use this evidence in four ways. First, ask every patient about supplements, since many do not mention them. Second, if a patient wants to try omega-3s, discuss them as a possible add-on to evidence-based treatment, not a substitute, and suggest an EPA-rich product from a reputable source. Third, measure progress with a standard scale such as the PHQ-9 so the patient and clinician can judge whether it helps. Fourth, review safety, including stomach upset and possible bleeding risk with anticoagulants.
I would also explain the uncertainty honestly: the best summary finds a small benefit that may not be noticeable, and fish oil does not prevent depression in older adults.
Limitations
Most trials were small and short, used different doses and formulas and enrolled varied populations, and supplement quality differs between brands. Few studies compared omega-3s directly with antidepressants.
Conclusion
Omega-3 fatty acids are a safe-appearing, popular alternative therapy with weak and inconsistent evidence for treating depression, a possible advantage for EPA-rich formulas and no role in prevention for older adults. Discussed honestly and measured carefully, they can be part of shared decision making in psychiatric practice.
References
Appleton, K. M., Voyias, P. D., Sallis, H. M., Dawson, S., Ness, A. R., Churchill, R., & Perry, R. (2021). Omega-3 fatty acids for depression in adults. Cochrane Database of Systematic Reviews, (11), Article CD004692. https://doi.org/10.1002/14651858.CD004692.pub5
Guu, T.-W., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R. K., Hamazaki, K., Freeman, M. P., Maes, M., Matsuoka, Y. J., Belmaker, R. H., Jacka, F., Pariante, C., Berk, M., Marx, W., & Su, K.-P. (2019). International Society for Nutritional Psychiatry Research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychotherapy and Psychosomatics, 88(5), 263-273. https://doi.org/10.1159/000502652
Liao, Y., Xie, B., Zhang, H., He, Q., Guo, L., Subramanieapillai, M., Fan, B., Lu, C., & McIntyre, R. S. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry, 9(1), Article 190. https://doi.org/10.1038/s41398-019-0515-5
Okereke, O. I., Vyas, C. M., Mischoulon, D., Chang, G., Cook, N. R., Weinberg, A., Bubes, V., Copeland, T., Friedenberg, G., Lee, I.-M., Buring, J. E., Reynolds, C. F., & Manson, J. E. (2021). Effect of long-term supplementation with marine omega-3 fatty acids vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: A randomized clinical trial. JAMA, 326(23), 2385-2394. https://doi.org/10.1001/jama.2021.21187
What the DNP 677 Module 3 instructions ask for
In the posted syllabus, the evidence-based paper on an alternative therapy relevant to psychiatric nursing practice is worth 100 points, or 15% of the course total, with further directions in Canvas under the course syllabus documents. The rubric awards 30 points for completeness of the review of the research, 30 for logic and interpretation of the research presented, 30 for relevance to psychiatric nursing practice and how the therapy can be incorporated, and 10 for composition and APA 7th edition. If you use AI anywhere in the paper, document where. Students share a brief summary of their paper on a later discussion board and say whether they could use it in their practicum. Pick a therapy with enough trials or reviews to support a complete research review.
Inside the DNP 677 Module 3 example
The paper introduces omega-3s and why patients ask about them. The research review groups studies by question: a Cochrane review for treatment, a meta-analysis on whether the formula matters, an expert guideline for practical use and a large trial for prevention. A logic section explains why the findings appear to disagree and weighs each by design before stating an overall interpretation. The practice section gives four concrete steps for a psychiatric nurse practitioner and a script for explaining uncertainty. Limits and a conclusion follow. Four sources support it, each verifiable by DOI. Each study is reported with its size, design and main result in numbers, followed by what that result means for a patient, which keeps the review accurate and readable at once.
Where the marks sit in the DNP 677 Module 3 rubric
The four rubric areas are completeness of the research review, logic and interpretation, relevance to practice, and APA composition. Completeness is stronger when the review includes systematic reviews, the best trials and any guideline. Logic and interpretation reward papers that explain conflicting results rather than list them, weighing study design and the question each study asks. Relevance earns its 30 points when the paper says how the therapy could be offered, monitored and discussed with patients, including safety. Writing and APA style carry the last 10 points, so check citations against the reference list. Expect faculty to notice whether the paper distinguishes a statistically significant effect from a clinically meaningful one.
DNP 677 Module 3 help from the desk
A frequent weakness is choosing a therapy with only small or poor-quality studies. Check for a systematic review before committing. Another is reporting only positive studies; include null and negative results, since faculty grade the completeness of the review. Separate treatment from prevention evidence. Send the desk your therapy and population if you want support drafting the paper. Document any AI use as the syllabus asks. Prepare a short summary for the later discussion board while the paper is fresh. Read at least one large trial yourself rather than relying on a review's summary, since a single well-run study can change how you interpret smaller ones.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More DNP 677 and Doctor of Nursing Practice sample papers
- DNP 677 Module 1: Vulnerable Family Review: Children of Parents With Mental Illness
- DNP 677 Module 2: Five-Generation Genogram Presentation
- DNP 679 Module 3: Paired t-Test Written Assignment
- DNP 713 Module 1: Organizational Culture Photo Diary
- DNP 673 Module 2: Effective Parenting Article Post
- DNP 711 Module 2: Blog 2: Stakeholders in the Policy Topic
DNP 677 Module 3 questions, answered
Where can I find a free DNP 677 Module 3 sample paper?
The complete DNP 677 alternative therapy paper sample, reviewing omega-3 fatty acids for adults with depression with a Cochrane review, a meta-analysis, a guideline and a large trial, appears on this page.
How is the DNP 677 alternative therapy paper graded?
The posted syllabus awards 30 points each for research review, logic and interpretation, and relevance to psychiatric nursing practice, plus 10 for APA composition.
Does fish oil help depression?
A Cochrane review found a small benefit unlikely to be clinically meaningful, while some analyses suggest EPA-rich formulas may help as an add-on.
Can omega-3 supplements prevent depression?
A trial of more than 18,000 older adults found that five years of omega-3 supplements did not prevent depression.
What alternative therapies could I write about for DNP 677?
Options with research include omega-3 fatty acids, St. John's wort, light therapy, yoga, acupuncture and mindfulness-based programs.